By: Clayton R. Boldt, Ph.D. From: mdanderson.org The Therapeutics Discovery division at MD Anderson Cancer Center has advanced a new small-molecule inhibitor of cancer metabolism to Phase I clinical trials. This new drug candidate marks the fourth novel therapeutic brought from concept to clinical trial by Therapeutics Discovery, a drug-discovery engine built within the walls of MD Anderson to eliminate …
The “In the News” Cancer Information Feature Is Now Six Years Old
View PostCreating a Support System for Caregivers and Families
View PostValuable Information for Cancer Patients and Their Loved Ones in A Live Online Event
Calling All Cancer Patients, Cargivers and Loved Ones! Don’t miss out on this Facebook Live interview on Thursday May 9, 2019 at 2 pm ET. Johns Hopkins School of Medicine Professor of Breast Cancer Lillie D. Shockney, RN will share information regarding reporting the side effects of cancer treatments and how to support a loved one that should be extremely …
Dealing With the Side Effects of Your Cancer Treatment
View PostPBM Delays for Cancer Drugs May Risk Lives, Warn Oncologists
By: Alicia Ault From: medscape.com The patient had metastatic kidney cancer, and his oncologist was seeking to treat him with sunitinib malate (Sutent, Pfizer), a preferred first-line oral therapy. But the patient’s pharmacy benefit manager (PBM) refused to cover the cost of the medication. The PBM told the oncologist that the patient’s kidney must first be removed. However, the patient’s …
Cancer: How Do You Choose the Right Doctor for You
View PostAsking Questions About Your Cancer Treatment Is Really Hard
View PostBacteria-Based Drug Delivery System Outperforms Conventional Methods
By: Virginia Tech From: labmanager.com A new drug delivery system could radically expand cancer treatment options An interdisciplinary team of three Virginia Tech faculty members affiliated with the Macromolecules Innovation Institute has created a drug delivery system that could radically expand cancer treatment options. The conventional cancer treatment method of injecting nanoparticle drugs into the bloodstream results in low efficacy. …
2 Trials, Now Enrolling, Aimed at Improving Breast Cancer Prevention, Diagnosis, and Treatment
By: Patricia Inacio, PhD From: breastcancer-news.com The University of Hawaiʻi Cancer Center is enrolling participants in two clinical trials to test new ways of preventing and diagnosing breast cancer, as well as improving current treatments. “These trials are very important because breast cancer is a significant issue in Hawaiʻi,” Randall Holcombe, director of the UH Cancer Center said in a press release. “Racial and ethnic minority …